Trial Profile
A Phase I Trial of Indoximod and Temozolomide-Based Therapy for Children With Progressive Primary Brain Tumors
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 05 Jun 2020
Price :
$35
*
At a glance
- Drugs Indoximod (Primary) ; Temozolomide (Primary) ; Cyclophosphamide; Etoposide
- Indications Brain cancer; CNS cancer; Diffuse intrinsic pontine glioma; Ependymoma; Glioma; Medulloblastoma
- Focus Adverse reactions; Therapeutic Use
- Sponsors NewLink Genetics Corporation
- 03 Jun 2020 Status changed from active, no longer recruiting to completed.
- 23 Jan 2020 Planned End Date changed from 1 Dec 2019 to 1 Mar 2020.
- 23 Jan 2020 Status changed from recruiting to active, no longer recruiting.